poLight (PLT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Achieved record-high Q4 2025 revenue of NOK 8.6 million, driven by strong AR/MR market traction, multiple strategic contracts, and new and repeat orders from top-tier OEMs and industrial customers.
Significant progress in TLens, TWedge, and MLens product lines, with several design wins and maturing PoC projects across consumer, enterprise, industrial, and healthcare segments.
Launched MLens for industrial machine vision, received positive feedback and initial orders, and advanced lead-free TLens development.
Organization strengthened to support increased activity, with plans to increase headcount and ongoing investments in R&D and hiring.
Financial highlights
Q4 2025 revenue: NOK 8.6 million (up from NOK 1.2 million in Q4 2024); FY 2025 revenue: NOK 20.5 million (up from NOK 9.6 million in FY 2024).
Gross margin reached 60% in Q4 2025, aided by inventory adjustments and high-value orders.
EBITDA for Q4 2025: NOK -32.8 million (Q4 2024: NOK -32.3 million); FY 2025 EBITDA: NOK -116.5 million.
Cash and cash equivalents at year-end: NOK 284.0 million, up from NOK 166.8 million at end-2024.
Inventory at NOK 53.5 million, mainly in wafers, with annual write-downs for prudency.
Outlook and guidance
Long-term outlook remains highly positive, especially for AR/MR, with several consumer PoCs expected to reach key milestones in 2026.
TWedge sampling to continue through H1 2026, with mass production readiness targeted in about two years.
Operational costs expected to rise in 2026 due to increased hiring and ongoing R&D investments.
No specific financial guidance or cash-positive timeline provided due to high uncertainty and market dependencies.
Latest events from poLight
- AR/MR and TWedge segments show strong momentum, with investments supporting future growth.PLT
Investor update2 Mar 2026 - AR/MR and industrial momentum grows, cash up, smartphone market remains challenging.PLT
Q2 20241 Feb 2026 - AR/MR and industrial momentum grew despite lower revenue; liquidity boosted by rights issue.PLT
Q1 202431 Jan 2026 - AR/MR and consumer markets prioritized, with new tech and strong pipeline driving growth from 2026.PLT
CMD 202431 Jan 2026 - Revenue fell, but AR/MR and healthcare pipelines grew, backed by strong cash reserves.PLT
Q3 202417 Jan 2026 - Expanding in AR/MR and consumer markets, with strong tech and strategic customer engagement.PLT
Investor Update12 Jan 2026 - AR/MR and industrial segments show strong momentum, with robust financials and expanding PoCs.PLT
Investor Update26 Dec 2025 - Q1 2025 revenue climbed, losses widened, and Q Tech investment boosts AR/MR prospects.PLT
Q1 202523 Dec 2025 - Tunable lens tech gains traction in AR/MR, with strong consumer pipeline and strategic backing.PLT
ABGSC Investor Days4 Dec 2025